This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsTB SA Acquisition（TBSA）株式概要TB SA Acquisition Corp does not have significant operations. 詳細TBSA ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績1/6財務の健全性0/6配当金0/6リスク分析収益が 100 万ドル未満 ( $0 )マイナスの株主資本 負債は営業キャッシュフローで十分にカバーされていない 3年未満の財務データが利用可能 すべてのリスクチェックを見るTBSA Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$10.21該当なし内在価値ディスカウントEst. Revenue$PastFuture04m2016201920222025202620282031Revenue US$1.0Earnings US$0AdvancedSet Fair ValueView all narrativesTB SA Acquisition Corp 競合他社Orion Biotech OpportunitiesSymbol: OTCPK:ORIAMarket cap: US$255.8mSummit Healthcare AcquisitionSymbol: NasdaqCM:SMIHMarket cap: US$334.8mFrontier InvestmentSymbol: NasdaqCM:FICVMarket cap: US$82.8mMagnum Opus AcquisitionSymbol: NYSE:OPAMarket cap: US$125.2m価格と性能株価の高値、安値、推移の概要TB SA Acquisition過去の株価現在の株価US$10.2152週高値US$10.6052週安値US$9.75ベータ01ヶ月の変化0.25%3ヶ月変化1.54%1年変化4.56%3年間の変化n/a5年間の変化n/aIPOからの変化n/a最新ニュースお知らせ • Aug 16TB SA Acquisition Corp announced delayed 10-Q filingOn 08/15/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 10TB SA Acquisition Receives Non-Compliance Letter from NasdaqOn June 1, 2022, TB SA Acquisition Corp. (the Company") received a deficiency letter from The Nasdaq Stock Market LLC (Nasdaq") indicating that it was not in compliance with Section 5250(c) of Nasdaq Rules regarding theQualification, Listing and Delisting of Companies (the Nasdaq Listing Rules") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the Form 10-Q") with the Securities and Exchange Commission (the SEC") through the SEC's EDGAR System. On May 16, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the Form 12b-25"), indicating that the filing of its Form 10-Q will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its financial statements and related disclosures for inclusion in the Form 10-Q, the Company was unable to complete and file the Form 10-Q prior to May 21, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-Q in order to ensure a complete, accurate Quarterly Report. Under the Nasdaq Listing Rules, the Company has 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules.お知らせ • May 17TB SA Acquisition Corp announced delayed 10-Q filingOn 05/16/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 26TB SA Acquisition Corp Announces Receipt of NASDAQ Continued Listing Standard NoticeTB SA Acquisition Corp. announced that on April 19, 2022 it received a deficiency letter from The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”) as required under Section 5250(c) of Nasdaq Rules regarding the Qualification, Listing and Delisting of Companies (the “Nasdaq Listing Rules”). On April 1, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the “Form 12b-25”), indicating that the filing of its Form 10-K will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its audited consolidated financial statements and related disclosures for inclusion in the Form 10-K, the Company was unable to complete and file the Form 10-K prior to April 15, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-K in order to ensure a complete, accurate Annual Report. The delay is due primarily to additional information and investigation needed in relation to the Company’s financial statements to complete the audit. In the course of its audit, the Company identified material weaknesses in its internal control over financial reporting related to its accounting for complex financial instruments and over the evaluation of vesting terms and recording of stock compensation expense. This further determination and related work and procedures resulted in the Company requiring additional time beyond the 15-day period provided by Rule 12b-25 to complete and file the Form 10-K. Under Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company generally has until 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan (the “Compliance Plan”) to regain compliance with the Nasdaq Listing Rules. The Company intends to submit the Compliance Plan as soon as practicable. The Company is in compliance with all other Nasdaq continued listing standards. The Company expects to file the Form 10-K in the very near term and does not foresee any risk of non-compliance with the Nasdaq 60-day remediation timeframe. The Nasdaq notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq.お知らせ • Apr 03TB SA Acquisition Corp announced delayed annual 10-K filingOn 04/01/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 14TB SA Acquisition Corp announced delayed 10-Q filingOn 08/13/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.最新情報をもっと見るRecent updatesお知らせ • Aug 16TB SA Acquisition Corp announced delayed 10-Q filingOn 08/15/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 10TB SA Acquisition Receives Non-Compliance Letter from NasdaqOn June 1, 2022, TB SA Acquisition Corp. (the Company") received a deficiency letter from The Nasdaq Stock Market LLC (Nasdaq") indicating that it was not in compliance with Section 5250(c) of Nasdaq Rules regarding theQualification, Listing and Delisting of Companies (the Nasdaq Listing Rules") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the Form 10-Q") with the Securities and Exchange Commission (the SEC") through the SEC's EDGAR System. On May 16, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the Form 12b-25"), indicating that the filing of its Form 10-Q will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its financial statements and related disclosures for inclusion in the Form 10-Q, the Company was unable to complete and file the Form 10-Q prior to May 21, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-Q in order to ensure a complete, accurate Quarterly Report. Under the Nasdaq Listing Rules, the Company has 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules.お知らせ • May 17TB SA Acquisition Corp announced delayed 10-Q filingOn 05/16/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 26TB SA Acquisition Corp Announces Receipt of NASDAQ Continued Listing Standard NoticeTB SA Acquisition Corp. announced that on April 19, 2022 it received a deficiency letter from The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”) as required under Section 5250(c) of Nasdaq Rules regarding the Qualification, Listing and Delisting of Companies (the “Nasdaq Listing Rules”). On April 1, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the “Form 12b-25”), indicating that the filing of its Form 10-K will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its audited consolidated financial statements and related disclosures for inclusion in the Form 10-K, the Company was unable to complete and file the Form 10-K prior to April 15, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-K in order to ensure a complete, accurate Annual Report. The delay is due primarily to additional information and investigation needed in relation to the Company’s financial statements to complete the audit. In the course of its audit, the Company identified material weaknesses in its internal control over financial reporting related to its accounting for complex financial instruments and over the evaluation of vesting terms and recording of stock compensation expense. This further determination and related work and procedures resulted in the Company requiring additional time beyond the 15-day period provided by Rule 12b-25 to complete and file the Form 10-K. Under Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company generally has until 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan (the “Compliance Plan”) to regain compliance with the Nasdaq Listing Rules. The Company intends to submit the Compliance Plan as soon as practicable. The Company is in compliance with all other Nasdaq continued listing standards. The Company expects to file the Form 10-K in the very near term and does not foresee any risk of non-compliance with the Nasdaq 60-day remediation timeframe. The Nasdaq notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq.お知らせ • Apr 03TB SA Acquisition Corp announced delayed annual 10-K filingOn 04/01/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 14TB SA Acquisition Corp announced delayed 10-Q filingOn 08/13/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 19TB SA Acquisition Corp announced delayed 10-Q filingOn 05/18/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.株主還元TBSAUS Capital MarketsUS 市場7D0.05%0.7%-4.1%1Y4.6%7.6%20.6%株主還元を見る業界別リターン: TBSA過去 1 年間で7.6 % の収益を上げたUS Capital Markets業界を上回りました。リターン対市場: TBSA過去 1 年間で20.6 % の収益を上げたUS市場を上回りました。価格変動Is TBSA's price volatile compared to industry and market?TBSA volatilityTBSA Average Weekly Movement0.2%Capital Markets Industry Average Movement3.6%Market Average Movement7.2%10% most volatile stocks in US Market16.6%10% least volatile stocks in US Market3.1%安定した株価: TBSA 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: TBSAの 週次ボラティリティ ( 0% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2021n/aAndrew Rolfen/aもっと見るTB SA Acquisition Corp 基礎のまとめTB SA Acquisition の収益と売上を時価総額と比較するとどうか。TBSA 基礎統計学時価総額US$255.13m収益（TTM）US$4.37m売上高(TTM)n/a58.4xPER（株価収益率0.0xP/SレシオTBSA は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計TBSA 損益計算書（TTM）収益US$0売上原価US$0売上総利益US$0その他の費用-US$4.37m収益US$4.37m直近の収益報告Sep 30, 2022次回決算日該当なし一株当たり利益（EPS）0.17グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率-17.1%TBSA の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/03/15 04:45終値2023/03/13 00:00収益2022/09/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋TB SA Acquisition Corp これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 16TB SA Acquisition Corp announced delayed 10-Q filingOn 08/15/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 10TB SA Acquisition Receives Non-Compliance Letter from NasdaqOn June 1, 2022, TB SA Acquisition Corp. (the Company") received a deficiency letter from The Nasdaq Stock Market LLC (Nasdaq") indicating that it was not in compliance with Section 5250(c) of Nasdaq Rules regarding theQualification, Listing and Delisting of Companies (the Nasdaq Listing Rules") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the Form 10-Q") with the Securities and Exchange Commission (the SEC") through the SEC's EDGAR System. On May 16, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the Form 12b-25"), indicating that the filing of its Form 10-Q will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its financial statements and related disclosures for inclusion in the Form 10-Q, the Company was unable to complete and file the Form 10-Q prior to May 21, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-Q in order to ensure a complete, accurate Quarterly Report. Under the Nasdaq Listing Rules, the Company has 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules.
お知らせ • May 17TB SA Acquisition Corp announced delayed 10-Q filingOn 05/16/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 26TB SA Acquisition Corp Announces Receipt of NASDAQ Continued Listing Standard NoticeTB SA Acquisition Corp. announced that on April 19, 2022 it received a deficiency letter from The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”) as required under Section 5250(c) of Nasdaq Rules regarding the Qualification, Listing and Delisting of Companies (the “Nasdaq Listing Rules”). On April 1, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the “Form 12b-25”), indicating that the filing of its Form 10-K will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its audited consolidated financial statements and related disclosures for inclusion in the Form 10-K, the Company was unable to complete and file the Form 10-K prior to April 15, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-K in order to ensure a complete, accurate Annual Report. The delay is due primarily to additional information and investigation needed in relation to the Company’s financial statements to complete the audit. In the course of its audit, the Company identified material weaknesses in its internal control over financial reporting related to its accounting for complex financial instruments and over the evaluation of vesting terms and recording of stock compensation expense. This further determination and related work and procedures resulted in the Company requiring additional time beyond the 15-day period provided by Rule 12b-25 to complete and file the Form 10-K. Under Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company generally has until 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan (the “Compliance Plan”) to regain compliance with the Nasdaq Listing Rules. The Company intends to submit the Compliance Plan as soon as practicable. The Company is in compliance with all other Nasdaq continued listing standards. The Company expects to file the Form 10-K in the very near term and does not foresee any risk of non-compliance with the Nasdaq 60-day remediation timeframe. The Nasdaq notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq.
お知らせ • Apr 03TB SA Acquisition Corp announced delayed annual 10-K filingOn 04/01/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 14TB SA Acquisition Corp announced delayed 10-Q filingOn 08/13/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16TB SA Acquisition Corp announced delayed 10-Q filingOn 08/15/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 10TB SA Acquisition Receives Non-Compliance Letter from NasdaqOn June 1, 2022, TB SA Acquisition Corp. (the Company") received a deficiency letter from The Nasdaq Stock Market LLC (Nasdaq") indicating that it was not in compliance with Section 5250(c) of Nasdaq Rules regarding theQualification, Listing and Delisting of Companies (the Nasdaq Listing Rules") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the Form 10-Q") with the Securities and Exchange Commission (the SEC") through the SEC's EDGAR System. On May 16, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the Form 12b-25"), indicating that the filing of its Form 10-Q will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its financial statements and related disclosures for inclusion in the Form 10-Q, the Company was unable to complete and file the Form 10-Q prior to May 21, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-Q in order to ensure a complete, accurate Quarterly Report. Under the Nasdaq Listing Rules, the Company has 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules.
お知らせ • May 17TB SA Acquisition Corp announced delayed 10-Q filingOn 05/16/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 26TB SA Acquisition Corp Announces Receipt of NASDAQ Continued Listing Standard NoticeTB SA Acquisition Corp. announced that on April 19, 2022 it received a deficiency letter from The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”) as required under Section 5250(c) of Nasdaq Rules regarding the Qualification, Listing and Delisting of Companies (the “Nasdaq Listing Rules”). On April 1, 2022, the Company filed Notification of Late Filing on Form 12b-25 (the “Form 12b-25”), indicating that the filing of its Form 10-K will be delayed. Although the Company has dedicated significant resources to the completion of finalizing its audited consolidated financial statements and related disclosures for inclusion in the Form 10-K, the Company was unable to complete and file the Form 10-K prior to April 15, 2022, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-K in order to ensure a complete, accurate Annual Report. The delay is due primarily to additional information and investigation needed in relation to the Company’s financial statements to complete the audit. In the course of its audit, the Company identified material weaknesses in its internal control over financial reporting related to its accounting for complex financial instruments and over the evaluation of vesting terms and recording of stock compensation expense. This further determination and related work and procedures resulted in the Company requiring additional time beyond the 15-day period provided by Rule 12b-25 to complete and file the Form 10-K. Under Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company generally has until 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan (the “Compliance Plan”) to regain compliance with the Nasdaq Listing Rules. The Company intends to submit the Compliance Plan as soon as practicable. The Company is in compliance with all other Nasdaq continued listing standards. The Company expects to file the Form 10-K in the very near term and does not foresee any risk of non-compliance with the Nasdaq 60-day remediation timeframe. The Nasdaq notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq.
お知らせ • Apr 03TB SA Acquisition Corp announced delayed annual 10-K filingOn 04/01/2022, TB SA Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 14TB SA Acquisition Corp announced delayed 10-Q filingOn 08/13/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 19TB SA Acquisition Corp announced delayed 10-Q filingOn 05/18/2021, TB SA Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.